US Pharma MarketingTwo-thirds of health leaders concerned about Medicare, Medicaid cuts’ impact on business operations
Two-thirds of health leaders concerned about Medicare, Medicaid cuts’ impact on business operations is a pharma and life sciences industry update from Fierce Healthcare. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
If potential reimbursement cuts exceed 10%, respondents say it will have negative impacts on staffing decisions and technological investments.
Source: Fierce Healthcare